Peptide Report
GHK-Cu Peptide Report
Catalog report for GHK-Cu, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$49.99 – $89.99 CAD
Common Uses
People commonly use GHK-Cu for skin, hair, and appearance-focused routines, with interest often centered on skin tone, visible aging, recovery, and copper peptide support.
How It Works
GHK-Cu is a copper-binding tripeptide. It works by delivering copper into signaling contexts tied to collagen and elastin remodeling, antioxidant enzyme activity, inflammatory balance, wound-healing pathways, and gene-expression changes in skin research.
Storage
Powder form: In lyophilized powder form, GHK-Cu is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, GHK-Cu should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full GHK-Cu protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Reconstitution examples, syringe conversion and community-reported usage patterns.
Available strengths: 50 MG and 100 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 50 MG vial example |
Add 2.5 mL bacteriostatic water |
20 mg/mL |
Each U-100 unit = 0.20 mg |
| 100 MG vial example |
Add 3.0 mL bacteriostatic water |
33.33 mg/mL |
Each U-100 unit = about 0.333 mg |
Syringe Conversion
| Reported amount |
50 MG setup |
100 MG setup |
| 0.5 mg |
2.5 units |
1.5 units |
| 1 mg |
5 units |
3 units |
| 2 mg |
10 units |
6 units |
| 3 mg |
15 units |
9 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report |
Frequency seen |
Context in reports |
| 0.5-1 mg |
Daily or near-daily |
Lower-start reports |
| 2 mg |
Daily or 5 days/week |
Most recurring amount reviewed |
| Above 2 mg |
Daily in some posts |
Highly variable, less consistent |
Observations
- Across the reviewed discussions, 1-2 mg was the most repeated daily amount.
- Six-to-eight-week runs appeared in multiple discussions, but cycle structure was not consistent.
- Contributors repeatedly warned that syringe units are meaningless without vial strength and diluent volume.
Caveats
- Injection-site burning or irritation was frequently discussed; severity and mitigation reports varied.
- Copper balance and zinc supplementation were discussed by users, but online community claims are not a substitute for laboratory monitoring or clinician guidance.